These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

328 related articles for article (PubMed ID: 27026367)

  • 1. Endothelin-1 Induces Proteinuria by Heparanase-Mediated Disruption of the Glomerular Glycocalyx.
    Garsen M; Lenoir O; Rops AL; Dijkman HB; Willemsen B; van Kuppevelt TH; Rabelink TJ; Berden JH; Tharaux PL; van der Vlag J
    J Am Soc Nephrol; 2016 Dec; 27(12):3545-3551. PubMed ID: 27026367
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of heparanase and the endothelial glycocalyx in the development of proteinuria.
    Garsen M; Rops AL; Rabelink TJ; Berden JH; van der Vlag J
    Nephrol Dial Transplant; 2014 Jan; 29(1):49-55. PubMed ID: 24166469
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vitamin D attenuates proteinuria by inhibition of heparanase expression in the podocyte.
    Garsen M; Sonneveld R; Rops AL; Huntink S; van Kuppevelt TH; Rabelink TJ; Hoenderop JG; Berden JH; Nijenhuis T; van der Vlag J
    J Pathol; 2015 Dec; 237(4):472-81. PubMed ID: 26202309
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Heparanase in Kidney Disease.
    van der Vlag J; Buijsers B
    Adv Exp Med Biol; 2020; 1221():647-667. PubMed ID: 32274730
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Endothelin receptor-A mediates degradation of the glomerular endothelial surface layer via pathologic crosstalk between activated podocytes and glomerular endothelial cells.
    Ebefors K; Wiener RJ; Yu L; Azeloglu EU; Yi Z; Jia F; Zhang W; Baron MH; He JC; Haraldsson B; Daehn I
    Kidney Int; 2019 Oct; 96(4):957-970. PubMed ID: 31402170
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hyperoside pre-treatment prevents glomerular basement membrane damage in diabetic nephropathy by inhibiting podocyte heparanase expression.
    An X; Zhang L; Yuan Y; Wang B; Yao Q; Li L; Zhang J; He M; Zhang J
    Sci Rep; 2017 Jul; 7(1):6413. PubMed ID: 28743882
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The receptor for advanced glycation endproducts mediates podocyte heparanase expression through NF-κB signaling pathway.
    An X; Zhang L; Yao Q; Li L; Wang B; Zhang J; He M; Zhang J
    Mol Cell Endocrinol; 2018 Jul; 470():14-25. PubMed ID: 28478303
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of podocytes for reversal of glomerulosclerosis and proteinuria in the aging kidney after endothelin inhibition.
    Ortmann J; Amann K; Brandes RP; Kretzler M; Münter K; Parekh N; Traupe T; Lange M; Lattmann T; Barton M
    Hypertension; 2004 Dec; 44(6):974-81. PubMed ID: 15545511
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Systemic Monocyte Chemotactic Protein-1 Inhibition Modifies Renal Macrophages and Restores Glomerular Endothelial Glycocalyx and Barrier Function in Diabetic Nephropathy.
    Boels MGS; Koudijs A; Avramut MC; Sol WMPJ; Wang G; van Oeveren-Rietdijk AM; van Zonneveld AJ; de Boer HC; van der Vlag J; van Kooten C; Eulberg D; van den Berg BM; IJpelaar DHT; Rabelink TJ
    Am J Pathol; 2017 Nov; 187(11):2430-2440. PubMed ID: 28837800
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Atrasentan Reduces Albuminuria by Restoring the Glomerular Endothelial Glycocalyx Barrier in Diabetic Nephropathy.
    Boels MG; Avramut MC; Koudijs A; Dane MJ; Lee DH; van der Vlag J; Koster AJ; van Zonneveld AJ; van Faassen E; Gröne HJ; van den Berg BM; Rabelink TJ
    Diabetes; 2016 Aug; 65(8):2429-39. PubMed ID: 27207530
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Heparanase inhibition as a systemic approach to protect the endothelial glycocalyx and prevent microvascular complications in diabetes.
    Gamez M; Elhegni HE; Fawaz S; Ho KH; Campbell NW; Copland DA; Onions KL; Butler MJ; Wasson EJ; Crompton M; Ramnath RD; Qiu Y; Yamaguchi Y; Arkill KP; Bates DO; Turnbull JE; Zubkova OV; Welsh GI; Atan D; Satchell SC; Foster RR
    Cardiovasc Diabetol; 2024 Feb; 23(1):50. PubMed ID: 38302978
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Beneficial effect on podocyte number in experimental diabetic nephropathy resulting from combined atrasentan and RAAS inhibition therapy.
    Hudkins KL; Wietecha TA; Steegh F; Alpers CE
    Am J Physiol Renal Physiol; 2020 May; 318(5):F1295-F1305. PubMed ID: 32249614
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Heparanase is essential for the development of diabetic nephropathy in mice.
    Gil N; Goldberg R; Neuman T; Garsen M; Zcharia E; Rubinstein AM; van Kuppevelt T; Meirovitz A; Pisano C; Li JP; van der Vlag J; Vlodavsky I; Elkin M
    Diabetes; 2012 Jan; 61(1):208-16. PubMed ID: 22106160
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Glomerular endothelial glycocalyx constitutes a barrier to protein permeability.
    Singh A; Satchell SC; Neal CR; McKenzie EA; Tooke JE; Mathieson PW
    J Am Soc Nephrol; 2007 Nov; 18(11):2885-93. PubMed ID: 17942961
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Protective role of podocyte autophagy against glomerular endothelial dysfunction in diabetes.
    Yoshibayashi M; Kume S; Yasuda-Yamahara M; Yamahara K; Takeda N; Osawa N; Chin-Kanasaki M; Nakae Y; Yokoi H; Mukoyama M; Asanuma K; Maegawa H; Araki SI
    Biochem Biophys Res Commun; 2020 Apr; 525(2):319-325. PubMed ID: 32089264
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Heparanase Is Essential for the Development of Acute Experimental Glomerulonephritis.
    Garsen M; Benner M; Dijkman HB; van Kuppevelt TH; Li JP; Rabelink TJ; Vlodavsky I; Berden JH; Rops AL; Elkin M; van der Vlag J
    Am J Pathol; 2016 Apr; 186(4):805-15. PubMed ID: 26873445
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Peroxisome proliferator-activated receptor ɣ agonist mediated inhibition of heparanase expression reduces proteinuria.
    Garsen M; Buijsers B; Sol M; Gockeln L; Sonneveld R; van Kuppevelt TH; de Graaf M; van den Born J; Kamps JAAM; van Raalte DH; van der Meer RW; Lamb HJ; Hillebrands JL; Rabelink TJ; Maciej-Hulme ML; Krenning G; Nijenhuis T; van der Vlag J
    EBioMedicine; 2023 Apr; 90():104506. PubMed ID: 36889064
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reduction of anionic sites in the glomerular basement membrane by heparanase does not lead to proteinuria.
    van den Hoven MJ; Wijnhoven TJ; Li JP; Zcharia E; Dijkman HB; Wismans RG; Rops AL; Lensen JF; van den Heuvel LP; van Kuppevelt TH; Vlodavsky I; Berden JH; van der Vlag J
    Kidney Int; 2008 Feb; 73(3):278-87. PubMed ID: 18046314
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Heparanase-driven inflammation from the AGEs-stimulated macrophages changes the functions of glomerular endothelial cells.
    Xu G; Qin Q; Yang M; Qiao Z; Gu Y; Niu J
    Diabetes Res Clin Pract; 2017 Feb; 124():30-40. PubMed ID: 28081450
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Direct action of endothelin-1 on podocytes promotes diabetic glomerulosclerosis.
    Lenoir O; Milon M; Virsolvy A; Hénique C; Schmitt A; Massé JM; Kotelevtsev Y; Yanagisawa M; Webb DJ; Richard S; Tharaux PL
    J Am Soc Nephrol; 2014 May; 25(5):1050-62. PubMed ID: 24722437
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.